Yahoo Web Search

  1. Ads

    related to: Patents and Dyskinesia

Search results

    • Neurocrine Biosciences Announces CEO Succession Plan

      FOX 4 Kansas City· 1 day ago

      Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced that Kevin Gorman, Ph.D., will retire as Chief Executive Officer of Neurocrine on October 11, 2024. Kyle Gano, Ph.D., currently Neurocrine's ...